Red Flags Missed for Years: Arcadia Case Haunts the Industry

The Los Angeles Times reports that the parents at the center of the Arcadia surrogacy mansion case left a documented trail of warning signs over multiple years before child abuse charges were filed. The report surfaces concerns about whether existing screening systems caught or ignored those signals. The piece adds new depth to a case that has drawn international attention since the couple's arrest.

This is the detail that changes the conversation. The question is no longer only what happened inside that house. It is how the warning signs went unaddressed for so long, and what that means for the vetting processes agencies and clinics rely on.

France 24 profiles Thailand's growing reputation as a fertility tourism hub, with international patients increasingly choosing the country for IVF treatment. The report highlights Thailand's medical infrastructure and relative cost advantages as key draws for patients from across Asia and beyond. The piece comes amid continued shifts in where intended parents and patients seek care as regulatory environments vary by country.

If you are exploring international IVF options, destination reputation is a starting point, not a due-diligence checklist. Licensing standards, clinic accreditation, and what legal protections apply to you as a foreign patient all deserve direct answers before you book.

A judge from the African Court has again called on Ghana to enact comprehensive surrogacy legislation, citing the legal complexity of disputes that arise without a clear statutory framework. The call follows Ghana's highest court flagging citizenship and inheritance risks for surrogate-born children earlier this month. The judge's renewed push signals growing institutional pressure on Ghana's legislature to act.

Worth watching. Ghana is becoming a case study in what happens when judicial bodies outpace legislatures on surrogacy, and the ripple effects for families with ties to the country are real.

Surrogacy in the U.S. for International Intended Parents

Pursuing surrogacy in the United States as an international intended parent is absolutely possible, and many families around the world have built their families here successfully. That said, the process does involve a few additional layers of planning that are worth understanding from the very beginning.

One of the first practical considerations is travel. Intended parents typically need to travel to the U.S. at least twice — once early in the process for legal and medical appointments, and again around the time of birth. A B-1 or B-2 visitor visa is generally appropriate for these trips, though you should always confirm the right visa category with an immigration attorney who understands surrogacy travel specifically.

When your child is born in the United States, they will be a U.S. citizen by birthright, regardless of your nationality. This is a meaningful benefit, but it also means you will need to navigate two legal systems simultaneously: U.S. parentage law to establish your parental rights, and your home country's process to have those rights recognized and bring your child home. Some countries accept U.S. court orders readily; others require additional steps or have restrictions on surrogacy altogether. Researching your home country's laws early is essential.

Your child will need a U.S. passport to travel internationally. Most consulates will also require a DNA test confirming the biological relationship to at least one parent, along with the U.S. court order establishing parentage, before issuing any travel or entry documents for your home country.

Choosing the right U.S. state matters greatly. States like California, Nevada, Connecticut, and Washington are well known for having clear, surrogacy-friendly laws and courts experienced with international arrangements, which can make the legal process smoother and more predictable for families coming from abroad.